128 related articles for article (PubMed ID: 27062956)
1. Effect of honey on febrile neutropenia in children with acute lymphoblastic leukemia: A randomized crossover open-labeled study.
Abdulrhman MA; Hamed AA; Mohamed SA; Hassanen NA
Complement Ther Med; 2016 Apr; 25():98-103. PubMed ID: 27062956
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of episodes of febrile neutropenia in children with acute myeloid leukemia and acute lymphoblastic leukemia].
Ducasse K; Fernández JP; Salgado C; Alvarez AM; Avilés CL; Becker A; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
Rev Chilena Infectol; 2014 Jun; 31(3):333-8. PubMed ID: 25146209
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation in children with febrile neutropenia.
Yozgat AK; Eker İ; Gürsel O; Kılınçkaya MF; Kara A; Yaralı N; Özbek NY
Turk J Pediatr; 2021; 63(2):251-256. PubMed ID: 33929114
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin Clearance, CD64, and HLA-DR as Predictors of Outcome in Febrile Neutropenic Children With Lymphoreticular Malignancies.
Gomber S; Banerjee A; Dewan P; Das S; Ansari MA; Rai G; Singh P
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e416-e422. PubMed ID: 32590420
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia.
Polat MC; Sönmez Ç; Yarali N; Özbek NY
Eur J Pediatr; 2024 May; 183(5):2155-2162. PubMed ID: 38367066
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of guideline for treatment of febrile neutropenia in pediatric cancer at Siriraj Hospital.
Sanpakit K; Phuakpet K; Veerakul G; Narkbunnam N; Chokephaibulkit K
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S124-34. PubMed ID: 16858853
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with life-threatening infections in children with febrile neutropenia: a data mining approach.
Badiei Z; Khalesi M; Alami MH; Kianifar HR; Banihashem A; Farhangi H; Razavi AR
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e9-e12. PubMed ID: 21102352
[TBL] [Abstract][Full Text] [Related]
8. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia.
Hitoglou-Hatzi S; Hatzistilianou M; Gougoustamou D; Rekliti A; Agguridaki Ch; Athanassiadou F; Frydas S; Kotsis A; Catriu D
Clin Exp Med; 2005 Jul; 5(2):60-5. PubMed ID: 16096855
[TBL] [Abstract][Full Text] [Related]
9. Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil.
Dufrayer MC; Rechenmacher C; Meneses CF; Monteiro YMC; Carlesse FAMC; Motta F; Daudt LE; Michalowski MB
Braz J Infect Dis; 2023; 27(2):102745. PubMed ID: 36750202
[TBL] [Abstract][Full Text] [Related]
10. Mucocutaneous findings in febrile neutropenic children with acute leukemias.
Wananukul S; Nuchprayoon I; Siripanich H
J Med Assoc Thai; 2005 Jun; 88(6):817-23. PubMed ID: 16083222
[TBL] [Abstract][Full Text] [Related]
11. L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
Merlen C; Bonnefoy A; Wagner E; Dedeken L; Leclerc JM; Laverdière C; Rivard GE
Pediatr Blood Cancer; 2015 Aug; 62(8):1381-7. PubMed ID: 25820776
[TBL] [Abstract][Full Text] [Related]
12. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
Laoprasopwattana K; Khwanna T; Suwankeeree P; Sujjanunt T; Tunyapanit W; Chelae S
Pediatr Infect Dis J; 2013 Mar; 32(3):e94-8. PubMed ID: 23080291
[TBL] [Abstract][Full Text] [Related]
15. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
Abdelrazik N; Fouda M
Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
[TBL] [Abstract][Full Text] [Related]
16. Asymptomatic C-reactive protein elevation in neutropenic children.
Sugiura S; Ito T; Koyama N; Sasaki N; Ikai H; Imanaka Y
Pediatr Int; 2017 Jan; 59(1):23-28. PubMed ID: 27362735
[TBL] [Abstract][Full Text] [Related]
17. Dengue fever causing febrile neutropenia in children with acute lymphoblastic leukemia: an unknown entity.
Ramzan M; Yadav SP; Dinand V; Sachdeva A
Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):65-7. PubMed ID: 23756720
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia.
Aggarwal R; Bansal D; Bansal F; Nanda N; Ray P; Trehan A; Marwaha RK
Indian J Med Microbiol; 2013; 31(3):226-9. PubMed ID: 23883706
[TBL] [Abstract][Full Text] [Related]
19. Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.
Orme LM; Babl FE; Barnes C; Barnett P; Donath S; Ashley DM
Pediatr Blood Cancer; 2014 Aug; 61(8):1427-33. PubMed ID: 24604835
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of acute lymphoblastic leukemia and febrile neutropenia in children and adolescents cared for in a hospital in Guayaquil, Ecuador].
Fuentes L; Flores M; Iglesias A; Luzuriaga A; Rendón N; Ordoñez R; Solórzano F; Añez R
Rev Peru Med Exp Salud Publica; 2018; 35(2):272-278. PubMed ID: 30183921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
